Standard-of-Care Systemic Therapy

OTHER3 trials

Sponsors

Li Min, ElmediX

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Metastatic Solid TumorsOligometastatic DiseasePancreatic Ductal Adenocarcinoma (mPDAC)

Phase 2

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Not yet recruitingNCT07333651

Li MinOligometastatic Disease

Start: 2026-01-31End: 2028-01-01Target: 90Updated: 2026-01-12

Image-Guided 125I Seed Implantation Plus Standard Systemic Therapy for Patients With Multiple Metastatic Lesions

Not yet recruitingNCT07333664

Li MinMetastatic Solid Tumors

Start: 2026-01-31End: 2028-01-01Target: 120Updated: 2026-01-12

A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer

Not yet recruitingNCT07711067

ElmediXMetastatic Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma (mPDAC)

Start: 2026-10-01End: 2030-12-31Target: 95Updated: 2026-07-17